Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

Open Access 01-12-2020 | Suicide | Study protocol

Combined transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide: study protocol for a randomized controlled trial in veterans

Authors: Melanie L. Bozzay, Jennifer M. Primack, Hannah R. Swearingen, Jennifer Barredo, Noah S. Philip

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

At least 17 veterans die every day from suicide. Although existing treatments such as brief cognitive behavioral therapy (BCBT) have been found to reduce suicide attempts in military personnel, a number of patients go on to attempt suicide after completing therapy. Thus, finding ways to enhance treatment efficacy to reduce suicide is critical. Repetitive transcranial magnetic stimulation (TMS) is a noninvasive technique that can be used to stimulate brain regions that are impaired in suicidal patients, that has been successfully used to augment treatments for psychiatric disorders implicated in suicide. The goal of this study is to test whether augmenting BCBT with TMS in suicidal veterans reduces rates of suicidal ideation, attempts, and other deleterious treatment outcomes.

Methods

One hundred thirty veterans with a suicide plan or suicidal behavior in the prior 2 weeks will be recruited from inpatient and outpatient settings at the Providence VA Medical Center in the USA. Veterans will be randomly assigned to receive 30 daily sessions of active or sham TMS in concert with a 12-week BCBT protocol in a parallel group design. Veterans will complete interviews and questionnaires related to psychiatric symptoms, suicidal ideation and behavior, treatment utilization, and functioning during a baseline assessment prior to treatment, at treatment endpoint, and 6- and 12-month follow-ups. Primary analyses will use mixed effect regressions to examine effects of treatment condition on suicidal behaviors, improvements in psychosocial functioning, and psychiatric hospitalization. Similar models as well as exploratory latent growth curve analyses will examine mediators and moderators of treatment effects.

Discussion

This protocol provides a framework for designing multilayered treatment studies for suicide. When completed, this study will be the first clinical trial evaluating the efficacy of augmenting BCBT for suicide with TMS. The results of this trial will have implications for treatment of suicide ideation and behaviors and implementation of augmented treatment designs. If positive, results from this study can be rapidly implemented across the VA system and will have a direct and meaningful impact on veteran suicide.

Trial registration

This study was registered prior to participant enrollment with ClinicalTrials.gov NCT03952468. Registered on May 16, 2019.

Trial sponsor contact

Robert O’Brien (VA Health Services R&D), robert.​obrien7@va.​gov
Literature
1.
Affairs DoV. Suicide among Veterans and other Americans 2001–2014. Washington, DC: Office of Suicide Prevention; 2016.
2.
Jobes DA, Lento R, Brazaitis K. An evidence-based clinical approach to suicide prevention in the department of defense: the collaborative assessment and management of suicidality (CAMS). Mil Psychol. 2012;24(6):604–23.CrossRef
3.
Ghahramanlou-Holloway M, Cox DW, Greene FN. Post-admission cognitive therapy: a brief intervention for psychiatric inpatients admitted after a suicide attempt. Cogn Behav Pract. 2012;19(2):233–44.CrossRef
4.
Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757–66.PubMedCrossRef
5.
Brown GK, Karlin BE, Trockel M, Gordienko M, Yesavage J, Taylor CB. Effectiveness of cognitive behavioral therapy for veterans with depression and suicidal ideation. Arch Suicide Res. 2016;20(4):677–82.PubMedCrossRef
6.
Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT. Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. Jama. 2005;294(5):563–70.PubMedCrossRef
7.
Rudd MD. Brief cognitive behavioral therapy (BCBT) for suicidality in military populations. Mil Psychol. 2012;24(6):592–603.CrossRef
8.
Nelson HD, Denneson L, Low A, et al. Systematic review of suicide prevention in veterans. 2015.
9.
Nelson HD, Denneson LM, Low AR, et al. Suicide risk assessment and prevention: a systematic review focusing on veterans. Psychiatr Serv. 2017;68(10):1003–15.
10.
Bressler SL, Menon V. Large-scale brain networks in cognition: emerging methods and principles. Trends Cogn Sci. 2010;14(6):277–90.PubMedCrossRef
11.
Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 2001;24:167–202.PubMedCrossRef
12.
13.
Allen KJ, Bozzay ML, Edenbaum ER. Neurocognition and suicide risk in adults. Curr Behav Neurosci Rep. 2019;6(4):1–15.
14.
McGirr A, Renaud J, Seguin M, et al. An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord. 2007;97(1):203–9.PubMedCrossRef
15.
Carmi L, Tendler A, Bystritsky A, et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry. 2019;176(11):931–8.PubMedCrossRef
16.
Koek RJ, Roach J, Athanasiou N, van't Wout-Frank M, Philip NS. Neuromodulatory treatments for post-traumatic stress disorder (PTSD). Prog Neuro-Psychopharmacol Biol Psychiatry. 2019;92:148–60.CrossRef
17.
Osoegawa C, Gomes JS, Grigolon RB, et al. Non-invasive brain stimulation for negative symptoms in schizophrenia: an updated systematic review and meta-analysis. Schizophr Res. 2018;197:34–44.PubMedCrossRef
18.
George MS, Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology. 2010;35(1):301–16.PubMedCrossRef
19.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Group SoTC. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008–39.PubMedPubMedCentralCrossRef
20.
Segrave RA, Arnold S, Hoy K, Fitzgerald PB. Concurrent cognitive control training augments the antidepressant efficacy of tDCS: a pilot study. Brain stimulation. 2014;7(2):325–31.PubMedCrossRef
21.
Brunoni A, Boggio P, De Raedt R, et al. Cognitive control therapy and transcranial direct current stimulation for depression: a randomized, double-blinded, controlled trial. J Affect Disord. 2014;162:43–9.PubMedCrossRef
22.
van’t Wout-Frank M, Shea MT, Larson VC, Greenberg BD, Philip NS. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019;12(1):41–3.CrossRef
23.
Berlim M, Van den Eynde F, Tovar-Perdomo S, Daskalakis Z. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44(2):225–39.PubMedCrossRef
24.
Donse L, Padberg F, Sack AT, Rush AJ, Arns M. Simultaneous rTMS and psychotherapy in major depressive disorder: clinical outcomes and predictors from a large naturalistic study. Brain stimulation. 2018;11(2):337–45.PubMedCrossRef
25.
Philip NS, Barredo J, Aiken E, Carpenter LL. Neuroimaging mechanisms of therapeutic transcranial magnetic stimulation for major depressive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(3):211–22.PubMed
26.
Philip NS, Barredo J, van’t Wout-Frank M, Tyrka AR, Price LH, Carpenter LL. Network mechanisms of clinical response to transcranial magnetic stimulation in posttraumatic stress disorder and major depressive disorder. Biol Psychiatry. 2018;83(3):263–72.PubMedCrossRef
27.
Bozzay ML, Primack J, Barredo J, Philip NS. Transcranial magnetic stimulation to reduce suicidality–a review and naturalistic outcomes. J Psychiatr Res. 2020.
28.
Qin B, Dai L, Zheng Y. Efficacy of repetitive transcranial magnetic stimulation for alleviating clinical symptoms and suicidal ideation in elderly depressive patients: a randomized controlled trial. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37(1):97–101.PubMed
29.
Abdelnaim MA, Langguth B, Deppe M, et al. Anti-suicidal efficacy of repetitive transcranial magnetic stimulation in depressive patients: a retrospective analysis of a large sample. Frontiers in Psychiatry. 2020;10(929).
30.
31.
Rudd MD, Bryan CJ, Wertenberger EG, et al. Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up. Am J Psychiatr. 2015;172(5):441–9.PubMedCrossRef
32.
Linehan M, Heard H. Treatment History Interview-4 (THI-4). Seattle,WA: University of Washington; 1996.
33.
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRef
34.
First M, Williams J, Karg R, Spitzer R. Structured clinical interview for DSM-5—research version (SCID-5 for DSM-5, research version; SCID-5-RV). Arlington, VA: American Psychiatric Association; 2015. p. 1–94.
35.
Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: the Mclean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Personal Disord. 2003;17(6):568–73.CrossRef
36.
M. BTdlFJSJG. AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for use in primary health care. Geneva: World Health Organization (WHO); 1992.
37.
Berman ABH, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11:22–31.PubMedCrossRef
38.
Posner K, Brent D, Lucas C, et al. Columbia-suicide severity rating scale (C-SSRS). New York, NY: Columbia University Medical Center; 2008.
39.
Miller IW, Norman WH, Bishop SB, Dow MG. The modified scale for suicidal ideation: reliability and validity. J Consult Clin Psychol. 1986;54(5):724–5.PubMedCrossRef
40.
Nock MK, Holmberg EB, Photos VI, Michel BD. The self-injurious thoughts and behaviors interview: development, reliability, and validity in an adolescent sample. Psychol Assess. 2007;73:872–9.
41.
Keller MB, Lavori PW, Friedman B, et al. The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540–8.PubMedCrossRef
42.
Beck AT. Beck hopelessness scale. In: The Psychological Corporation; 1988.
43.
44.
Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18(1):65–87.PubMedCrossRef
45.
Derrogatis L. BSI brief symptom inventory: administration, scoring, and procedure manual. Minneapolis, MN: National Computer Systems; 1993.
46.
Üstün TB, Kostanjsek N, Chatterji S, Rehm J. Measuring health and disability: Manual for WHO disability assessment schedule. WHODAS 2.0. World Health Organization; 2010.
47.
Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019;176(11):939–48.PubMedPubMedCentralCrossRef
48.
Miller IW, Bishop S, Norman WH, Keitner G. Cognitive/behavioural therapy and pharmacotherapy with chronic, drug-refractory depressed inpatients: a note of optimism. Behav Cogn Psychother. 1985;13(4):320–7.CrossRef
49.
Miller IW, Keitner GI, Ryan CE, Solomon DA, Cardemil EV, Beevers CG. Treatment matching in the posthospital care of depressed patients. Am J Psychiatry. 2005;162(11):2131–8.PubMedPubMedCentralCrossRef
50.
Miller IW, Norman WH, Keitner GI. Cognitive-behavioral treatment of depressed inpatients: six- and twelve-month follow-up. Am J Psychiatry. 1989;146(10):1274–9.PubMedCrossRef
51.
Miller IW, Norman WH, Keitner GI, Bishop SB, Dow MG. Cognitive-behavioral treatment of depressed inpatients. Behav Ther. 1989;20(1):25–47.CrossRef
52.
Wei L. An application of an urn model to the design of sequential controlled clinical trials. J Am Stat Assoc. 1978;73(363):559–63.CrossRef
53.
Stout RL, Wirtz PW, Carbonari JP, Del Boca FK. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl. 1994;(s12):70–5.
54.
Bryan CJ, Rudd MD. Brief cognitive-behavioral therapy for suicide prevention. Guilford Publications; 2018.
55.
Beam W, Borckardt JJ, Reeves ST, George MS. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain stimulation. 2009;2(1):50–4.PubMedPubMedCentralCrossRef
56.
Council NR. The prevention and treatment of missing data in clinical trials. National Academies Press; 2010.
57.
Rush AJ, Bernstein IH, Trivedi MH, et al. An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry. 2006;59(6):493–501.PubMedCrossRef
58.
Ware JH, Harrington D, Hunter DJ, D'Agostino Sr RB. Missing data. In: Mass Medical Soc. 2012;367:1353–4.
59.
O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3):549–56.
60.
Lehr R. Sixteen S-squared over D-squared: a relation for crude sample size estimates. Stat Med. 1992;11(8):1099–102.PubMedCrossRef
61.
Miller IW, Camargo CA, Arias SA, et al. Suicide prevention in an emergency department population: the ED-SAFE study. JAMA psychiatry. 2017;74(6):563–70.PubMedPubMedCentralCrossRef
62.
Boudreaux ED, Miller I, Goldstein AB, et al. The emergency department safety assessment and follow-up evaluation (ED-SAFE): method and design considerations. Contemp Clin Trials. 2013;36(1):14–24.PubMedPubMedCentralCrossRef
63.
Liu B, Zhang Y, Zhang L, Li L. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry. 2014;14:1–9.
Metadata
Title
Combined transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide: study protocol for a randomized controlled trial in veterans
Authors
Melanie L. Bozzay
Jennifer M. Primack
Hannah R. Swearingen
Jennifer Barredo
Noah S. Philip
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04870-6

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Study protocol

Efficacy of one-stage cartilage repair using allogeneic mesenchymal stromal cells and autologous chondron transplantation (IMPACT) compared to nonsurgical treatment for focal articular cartilage lesions of the knee: study protocol for a crossover randomized controlled trial

Letter

The effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19): A structured summary of a study protocol for a randomised controlled trial

Research

Recruitment of low-income pregnant women into a dietary and dental care intervention: lessons from a feasibility trial

Study protocol

Effect of an educational booklet for prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial II, a study protocol of a randomized controlled trial

Research

Parental perspectives long term after neonatal clinical trial participation: a survey

Letter

A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial